PIE II: Pharmacological Intervention in the Elderly II
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine whether spironolactone will improve exercise
tolerance and quality of life in elderly patients with heart failure preserved ejection
fraction (HFPEF).
Phase:
Phase 3
Details
Lead Sponsor:
Wake Forest School of Medicine Wake Forest University